Pyxis Oncology Inc
(PYXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,243 | -120,717 | -84,616 | -56,942 | -31,380 |
| Depreciation Amortization | -417 | 709 | 517 | 317 | 158 |
| Accounts payable and accrued liabilities | -753 | -8,328 | -6,443 | -4,131 | -9,896 |
| Other Working Capital | -12,209 | 4,501 | -570 | -2,731 | -93 |
| Other Operating Activity | 5,781 | 34,500 | 19,164 | 12,096 | 13,532 |
| Operating Cash Flow | $-26,841 | $-89,335 | $-71,948 | $-51,391 | $-27,679 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -94,987 | N/A | N/A | N/A | N/A |
| PPE Investments | -4,406 | -6,399 | -4,541 | -275 | -146 |
| Investing Cash Flow | $-99,393 | $-6,399 | $-4,541 | $-275 | $-146 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 183 | 183 | 177 | 176 |
| Financing Cash Flow | $0 | $183 | $183 | $177 | $176 |
| Beginning Cash Position | 180,765 | 276,316 | 276,316 | 276,316 | 276,316 |
| End Cash Position | 54,531 | 180,765 | 200,010 | 224,827 | 248,667 |
| Net Cash Flow | $-126,234 | $-95,551 | $-76,306 | $-51,489 | $-27,649 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,841 | -89,335 | -71,948 | -51,391 | -27,679 |
| Capital Expenditure | -4,406 | -6,399 | -4,541 | -275 | -146 |
| Free Cash Flow | -31,247 | -95,734 | -76,489 | -51,666 | -27,825 |